[图书][B] Fibrosis: Etiology, Pathophysiology, Measurements, and Therapy

Y Zhao, P Hao, P Wang, F Lu, Y Liu - 2023 - books.google.com
Page 1 frontiers Research Topics Fibrosis: Etiology, pathophysiology, measurements, and
therapy Edited by Yuxia Zhao, Panpan Hao, Peizhe Wang, Fujian Lu and Yanping Liu …

[图书][B] Fibrosis in disease: An organ-based guide to disease pathophysiology and therapeutic considerations

MS Willis, CC Yates, JC Schisler - 2018 - Springer
As we enter into this new era of molecular medicine with an expanding body of knowledge
related to the molecular pathogenesis of human disease and an increasing recognition of …

A primer on current progress in cardiac fibrosis

D Al Hattab, MP Czubryt - Canadian journal of physiology and …, 2017 - cdnsciencepub.com
Cardiac fibrosis is a significant global health problem that is closely associated with multiple
forms of cardiovascular disease, including myocardial infarction, dilated cardiomyopathy …

Organ Fibrosis: Emerging diagnostic and therapeutic strategies

M Parola, M Pinzani - Molecular Aspects of Medicine, 2024 - iris.unito.it
Organ fibrosis is a very common condition affecting different organs and tissues following
chronic tissue injury. Organ fibrosis can be defined as an excess deposition of fibrillar …

[HTML][HTML] Understanding Fibrosis: Mechanisms, Clinical Implications, Current Therapies, and Prospects for Future Interventions

JC Ku, J Raiten, Y Li - Biomedical Engineering Advances, 2024 - Elsevier
Fibrosis is a prevalent and detrimental condition associated with various diseases with a
high impact on global morbidity and mortality rates. Despite its diverse causes and affected …

Fibrosis: from mechanisms to medicines

NC Henderson, F Rieder, TA Wynn - Nature, 2020 - nature.com
Fibrosis can affect any organ and is responsible for up to 45% of all deaths in the
industrialized world. It has long been thought to be relentlessly progressive and irreversible …

Fibrotic signaling in cardiomyopathies

S Ravi, MS Willis, JC Schisler - Fibrosis in Disease: An Organ-Based …, 2019 - Springer
Cardiomyopathies are a group of diseases characterized by abnormalities in structure and
function of the heart muscles (Abelmann, Prog Cardiovasc Dis. 1984; 27: 73–94). The …

Vascular Fibrosis and Disease

M Zhang, B Wang, KC Kent, LW Guo - … in Disease: An Organ-Based Guide …, 2019 - Springer
Fibrosis can lead to a broad range of diseases affecting essentially every organ. Thus,
interventions targeting fibrosis are expected to have profound therapeutic effects. However …

The pathogenesis of cardiac fibrosis

P Kong, P Christia, NG Frangogiannis - Cellular and molecular life …, 2014 - Springer
Cardiac fibrosis is characterized by net accumulation of extracellular matrix proteins in the
cardiac interstitium, and contributes to both systolic and diastolic dysfunction in many …

[HTML][HTML] Atherofibrosis-a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis-lessons for biomarker development

E Vassiliadis, N Barascuk… - American journal of …, 2013 - ncbi.nlm.nih.gov
The hallmark of a variety of fibrotic diseases such as liver fibrosis, lung fibrosis, skin fibrosis
and atherosclerosis is extensive extracellular matrix remodeling (ECMr) of the disease …